The American Academy of Orthopaedic Surgeons (AAOS) continues to demonstrate its commitment to advancing the quality of musculoskeletal care in a fully transparent and scientific way. Debuting today as a new member benefit, the AAOS Biologics Dashboard is a dynamic online tool designed to help orthopaedic surgeons navigate the approval status of biologic-based interventions. The development of the AAOS Biologics Dashboard is just one of several efforts within the Academy’s Biologics Initiative that offers evidence-based guidance to the musculoskeletal health community. An additional effort is the revision of two biologics-related position statements, recently approved by the AAOS Board of Directors.
University of Miami Researchers Launch First U.S. Trial Testing Platelet-Rich Plasma as Peyronie’s Disease Treatment
University of Miami Miller School of Medicine researchers are about to start recruiting for the first U.S. clinical trial looking at treating Peyronie’s disease, a painful and agonizing condition common in men, with platelet-rich plasma (PRP).